Trending:
Germany-based pharmaceutical company Boehringer Ingelheim is constructing a new large-scale cell culture (LSCC) facility at its site in Vienna, Austria.
Germany-based pharmaceutical company Boehringer Ingelheim is constructing a new large-scale cell culture (LSCC) facility at...
Read More...
Lonza is developing a new biomanufacturing complex at its biopark in Visp, Switzerland.
Read More...
In February 2018, US-based pharmaceutical company MSD announced its plans to develop a new biologics...
Read More...
Germany-based pharmaceutical company, Boehringer Ingelheim, is constructing a new tablet production facility in Ingelheim, Germany,...
Read More...
BeiGene Biologics is developing a new biologics manufacturing facility in Guangzhou in the Guangdong province...
Read More...
French pharmaceutical company Sanofi Pasteur has unveiled plans to build a new vaccine manufacturing facility...
Read More...
In June 2018, Chinese biopharmaceutical company WuXi Biologics announced the development of a new production...
Read More...
Biogen’s new biologics manufacturing facility is being developed in Luterbach near Solothurn, Switzerland.
Read More...
In June 2018, Pfizer announced plans to build a sterile injectables production facility at Portage...
Read More...
Germany-based pharmaceutical company Boehringer Ingelheim’s veterinary research and development (R&D) centre is located within its...
Read More...
Go Top
